Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Xspray Pharma Major Shareholding Notification 2020

Mar 31, 2020

3129_iss_2020-03-31_875a6001-5ee4-4220-bb85-b6a1636f63cc.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer XSpray Pharma AB (publ)

Holder

Fjärde AP-fonden

Instrument

Instrument Aktier
Before the transaction
Shares 1,368,500
Voting rights 1,368,500
Transaction
Reason for major shareholding notification Other
Date 27/03/2020
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 1,368,500
Directly held voting rights 1,368,500
Indirectly held voting rights 0
Percentage
Directly held shares 8.17 %
Directly held voting rights 8.17 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 8.17 % 1,368,500
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 8.17 % 1,368,500
Group
total
holdings
Voting rights
1,368,500
Percentage of voting rights 8.17

Notes (other relevant informations according to law) Flaggning pga upplistning, från First North till Nasdaq Stockholms huvudlista.

Published
31/03/2020 21:17
Contact
Name Jannis Kitsakis
Phone 070-6038023 Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25